Owen Kramer
MOHS-Micrographic Surgery · Elmhurst, ILNPI 1477086874
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 473 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,329, 7.2 times the $465 reported in 2019. Among mohs-micrographic surgery clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 473 payments — averaging $22.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Lilly USA, LLC$1K
- Regeneron Healthcare Solutions, Inc.$1K
- Sun Pharmaceutical Industries Inc.$882
- Johnson & Johnson$860
- Sanofi$647
- plus $3K from 23 others
What the payments were for
- Travel & lodging$160%
- Food & beverage$10,10897%
- Education$2853%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 100 | $2,081 |
| Lilly USA, LLC | 57 | $1,282 |
| Regeneron Healthcare Solutions, Inc. | 33 | $1,184 |
| Sun Pharmaceutical Industries Inc. | 41 | $882 |
| Johnson & Johnson | 36 | $860 |
| Sanofi | 16 | $647 |
| Galderma Laboratories, L.p. | 37 | $480 |
| Pfizer | 27 | $436 |
| Arcutis Biotherapeutics, Inc. | 26 | $399 |
| E.r. Squibb & Sons, L.L.C. | 23 | $372 |
| Novartis | 13 | $344 |
| Incyte Corporation | 14 | $315 |
| Amgen | 10 | $260 |
| Dermavant Sciences, Inc. | 11 | $216 |
| UCB, Inc. | 4 | $114 |
| LEO Pharma Inc. | 4 | $89 |
| Botanix SB Inc | 3 | $76 |
| Smith+Nephew | 1 | $60 |
| Organon | 4 | $56 |
| Boehringer Ingelheim | 2 | $52 |
| Verrica Pharmaceuticals Inc. | 2 | $39 |
| Almirall LLC | 2 | $38 |
| Mimedx Group, Inc. | 1 | $24 |
| Sandoz | 1 | $24 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Bristol Myers Squibb | 1 | $16 |
| Merz North America, Inc. | 1 | $15 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$353
How this compares
$10,409 in reported general payments places this provider in the 90th percentile of 40 mohs-micrographic surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 15 | $101,661 |
| Dupixent PenDupilumab | 13 | $46,674 |
| Clobetasol Propionate | 114 | $5,322 |
| Ketoconazole | 130 | $2,185 |
| Tacrolimus | 21 | $1,957 |
| Fluocinonide | 45 | $1,677 |
| Metronidazole | 34 | $1,658 |
| Doxycycline Monohydrate | 62 | $1,651 |
| Triamcinolone Acetonide | 110 | $1,074 |
| Fluorouracil | 12 | $906 |
| Clindamycin Phosphate | 16 | $765 |
| Hydrocortisone | 69 | $684 |
| Doxycycline Hyclate | 13 | $208 |
| Nystatin | 12 | $181 |
| ValacyclovirValacyclovir Hcl | 15 | $165 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Elmhurst
- Scott ZahnerHinsdale$55K
- Melanie ZahnerHinsdale$23K
- Kelly ParkNorthbrook$11K
- Todd JohnsonChicago$10K
- Simon YooChicago$10K
- Jeffrey McKennaCharleston$10K
- Daniel SchlessingerChicago$8K
- Aleksandar KrunicChicago$8K
- Ross PearlmanChicago$8K
- Sarah WilsonChicago$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.